首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Clinical Cancer Research

Clinical Cancer Research杂志,由American Association for Cancer Research Inc.出版,于1995年创刊,Semimonthly,出版语言English,ISSN:1078-0432,E-ISSN:1557-3265。

投稿咨询
Clinical Cancer Research
Clinical Cancer Research
Clinical Cancer Research
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
10.9
CiteScore
17.3
期刊收录
SCI、SCIE

Clinical Cancer Research(中文译名:《临床癌症研究》),ISSN:1078-0432,EISSN:1557-3265,是American Association for Cancer Research Inc.出版的国际性学术期刊,创刊于1995年,以Semimonthly形式稳定发行,2026年总发文量约457篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达10.9,2025年期刊CiteScore为17.3,2025年期刊自引率约1.8%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Clinical Cancer Research长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约2.1月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Canada、CHINA MAINLAND、GERMANY (FED REP GER)、Spain、France等为核心发文国家与地区;HARVARD UNIVERSITYUNIVERSITY OF TEXAS SYSTEM、MEMORIAL SLOAN KETTERING CANCER CENTER、DANA-FARBER CANCER INSTITUTE、UNIVERSITY OF CALIFORNIA SYSTEM、MASSACHUSETTS GENERAL HOSPITAL、UNIVERSITY OF PENNSYLVANIA等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学
1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学
1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 33 / 333

90.2

学科:ONCOLOGY SCIE Q1 25 / 333

92.64

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 29 / 328

91.3

学科:ONCOLOGY SCIE Q1 22 / 328

93.45


中国学者近期发文

1
Becotatug Vedotin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multicenter, Phase IIa Tria

Author:Xue, Liqiong; Han, Yaqian; Zhang, Qingyuan; Li, Xia; Fang, Meiyu; Zhong, Laiping; Wang, Siyang; Liu, Yanyan; Zhang, Songnan; Li, Zhiming; Guo, Ye

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 8, pp. 1445-1453. DOI: 10.1158/1078-0432.CCR-25-3930

2
Noninvasive Imaging Assessment of Tertiary Lymphoid Structures and Immunotherapy Response in Gastric Cancer: A Multicenter Stud

Author:Sun, Zepang; Li, Zhenhui; Ahmad, M. Usman; Zhu, Yun; Zhou, Zixia; Zhou, Kangneng; Wu, Lin; Chen, Chuanli; Yuan, Qingyu; Zhang, Taojun; Chen, Yan; Xie, Jingjing; Feng, Wanying; Xu, Yikai; Xiong, Wenjun; Wang, Wei; Li, Guoxin; Jiang, Yuming

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 8, pp. 1486-1498. DOI: 10.1158/1078-0432.CCR-25-3669

3
Dynamic ctDNA Monitoring Guides Early Treatment Intensification in Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemotherap

Author:Shen, Yu; Wei, Mingtian; He, Yazhou; Yang, Tinghan; Deng, Xiangbing; Wu, Qingbin; Chen, Haining; Fan, Rui; Liu, Yiqian; Li, Qingyun; Li, Feifei; Gu, Xiafei; Lu, Zijian; Qiu, Meng; Meng, Wenjian; Jiang, Dan; Wang, Ziqiang

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1293-1301. DOI: 10.1158/1078-0432.CCR-25-3774

4
Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classificatio

Author:Qu, Shanqiang; Pan, Qiuming; Zhang, Xin; Wang, Junxi; Li, Hongrui; Huang, Yudi; Liao, Kuilin; Ye, Zhi; Ainiwan, Yilamujiang; Yi, Guozhong; Li, Zhiyong; Liu, Junlu; Hou, Xiaomin; Xu, Haiyan; Chen, Zhuoyang; Mei, Fen; Liu, Tao; Zhang, Xi'an; Qi, Songtao; Huang, Guanglong

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1349-1361. DOI: 10.1158/1078-0432.CCR-25-2496

5
RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-623

Author:Pfeil, Alexander J.; Zhang, Tom; Cheng, Ryan; Mattar, Marissa S.; Gomez Marti, Juan Luis; Gili, Leo; Lai, Rachel; Khodos, Inna; Master, Rohan P.; Dix, Jenna-Marie; Gazzo, Andrea; Arbour, Kathryn C.; de Stanchina, Elisa; Febres-Aldana, Christopher A.; Ladanyi, Marc; Yang, Soo-Ryum; Somwar, Romel

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1362-1375. DOI: 10.1158/1078-0432.CCR-25-2734

6
Clinical Significance for Risk Stratification of Papillary Thyroid Cancer by TUMORFISHER Circulating Tumor Cell Techniqu

Author:Jiang, Liehao; Li, Xuejie; Ma, Tianyi; Zeng, Pingping; Tan, Zhuo; Zheng, Chuanming; Xu, Jiajie; Zhang, Lizhuo; Guo, Yaweng; Liang, Juyong; Pan, Yan; Teng, Weidong; Tao, Zekai; He, Jiantong; Yu, Haolan; Wang, Jiafeng; Hu, Zhiyuan; Ge, Minghua

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1313-1324. DOI: 10.1158/1078-0432.CCR-25-2694

7
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortiu

Author:Waliany, Sarah; Cooper, Alissa J.; Liu, Stephen V.; Gautschi, Oliver; Rotow, Julia K.; Smith, Katherine Emilie Rhoades; Weber, Urs M.; Lee, Dae Ho; Loong, Herbert H. F.; Patel, Jyoti D.; Pennell, Nathan A.; Nagasaka, Misako; Patel, Shetal A.; Tan, Daniel S. W.; Solomon, Benjamin J.; Kim, Tae Min; Pall, Georg; Riess, Jonathan W.; Sun, Lova; Fruh, Martin; Uy, Natalie F.; Gadgeel, Shirish; Feng, Jamie; Do, Andrew; Falcon, Christina; Leighl, Natasha B.; Baik, Christina S.; Lai, Gillianne G. Y.; Ou, S. Ignatius; Cheung, Kingsley S. Y.; Patil, Tejas; Mansfield, Aaron S.; Weiler, Daniela; Yeap, Beow Y.; Wirth, Lori J.; Gainor, Justin F.; Drilon, Alexander; Lin, Jessica J

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 6, pp. 1157-1168. DOI: 10.1158/1078-0432.CCR-25-4382

8
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinom

Author:Rischin, Danny; Hansen, Aaron R.; Cohen, Ezra E. W.; Tahara, Makoto; Harrington, Kevin J.; Haddad, Robert I.; Licitra, Lisa; Mehanna, Hisham; Ferris, Robert L.; Koralewski, Piotr; Penkov, Konstantin; Schenker, Michael; Spigel, David R.; Daste, Amaury; Hong, Min Hee; Guo, Ye; Chisamore, Michael J.; Washburn, Michael L.; Phillips-jones, Amy; Russell, John; Roy-ghanta, Sumita; Ellis, Catherine; Ballas, Marc; Le Tourneau, Christophe

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 6, pp. 1087-1099. DOI: 10.1158/1078-0432.CCR-25-1197

9
Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinom

Author:Pant, Shubham; Park, Joon Oh; Su, Wu-Chou; Loriot, Yohann; Carranza, Omar; Corassa, Marcelo; Doi, Toshihiko; Qin, Shukui; Tabernero, Josep; Prenen, Hans; Folprecht, Gunnar; Winter, Helen; Dal Molin, Graziela Z.; Shen, Lin; Qian, Jiaqi; Liao, Huimin; Thomas, Shibu; Sweiti, Hussein; Triantos, Spyros; Feng, Yin-Hsun

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 6, pp. 1136-1144. DOI: 10.1158/1078-0432.CCR-25-2264

10
Pyrotinib plus capecitabine with or withoutradiotherapyin patients with HER2-positive metastatic breast cancer and brain metastases: Amulticenter, retrospective-prospective, real-world study in China (Post-PERMEATE

Author:Niu, L.; Liang, X.; Wang, S.; Zhang, S.; Lv, Z.; Li, H.; Zhao, Y.; Yin, Y.; Song, Y.; Sun, G.; Zhao, B.; Cai, L.; Ouyang, Q.; Geng, C.; Yao, H.; Wu, X.; Chen, Z.; Jiang, Z.; Li, H.; Yan, M

Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue , pp. -. DOI:


在线咨询

Clinical Cancer Research

国际简称:CLIN CANCER RES参考译名:临床癌症研究

年发文量:457 CiteScore:17.3 是否预警:否 Gold OA文章占比:36.57% 研究类文章占比:88.84%

杂志社联系方式:AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

Clinical Cancer Research